medigraphic.com

2022, Number 1

<< Back Next >>

Rev Cuba Endoc 2022; 33 (1)

Laparoscopic restrictive bariatric surgery and its influence on metabolic syndrome

Otero SM, Labrada DA, Acosta SM

Language: Spanish
References: 48
Page:
PDF size: 251.05 Kb.


ABSTRACT

Introduction: Due to the proven benefits of this procedure, bariatric surgery is a treatment option for metabolic syndrome.
Objective: To describe the effects of laparoscopic gastric restrictive techniques in obese patients with associated metabolic syndrome.
Methods: A descriptive and prospective study was performed in 22 patients with a body mass index higher than or equal to 35 Kg/m2 and with diagnosis of metabolic syndrome; they had undergone surgery by laparoscopic restrictive techniques at the General Calixto García University Hospital, from November 2018 to January 2018 2020. The degree of obesity, waist circumference, percentage of overweight lost, percentage of excess body mass index lost, glucose, cholesterol, triglycerides, and antihypertensive and hypoglycemic treatment were studied.
Results: The average age was 41.8±10.6 years, with predominance of women. Body mass index decreased at one year, as did waist circumference. The mean per year of the percentage of overweight lost and the percentage of excess body mass index lost was 75% and 83%, respectively. Blood glucose, cholesterol and triglyceride levels decreased compared to preoperative values. 78.6% of diabetics managed to suspend all medication and 81.2% hypertensive.
Conclusions: The degree of obesity, the percentage of overweight lost, the percentage of excess body mass index lost and the waist circumference decreased significantly. Blood glucose, triglycerides, and cholesterol values decreased significantly compared to baseline, with a decrease in the use of hypoglycemic and antihypertensive drugs.


REFERENCES

  1. Abete I, Arriola L, Etxezarreta N, Mozo I, Moreno-Iribas C, Amiano P, et al. Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort. Eur J Nutr. 2015;54(3):365-75. DOI: https://doi.org/10.1007/s00394-014-0716-x

  2. Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23(3):512-8. DOI: https://doi.org/10.1002/oby.21003

  3. Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23(4):591-601. DOI: https://doi.org/10.1016/j.cmet.2016.02.005

  4. Revelo XS, Luck H, Winer S, Winer DA. Morphological and inflammatory changes in visceral adipose tissue during obesity. Endocr Pathol. 2014;25(1):93-101. DOI: https://doi.org/10.1007/s12022-013-9288-1

  5. Peinado Martínez M, Dager Vergara I, Quintero Molano K, Mogollón Perez M, Puello Ospina A. Síndrome metabólico en adultos: Revisión narrativa de la literatura. Archivos de Medicina. 2021 [acceso: 23/01/2021];17(2:4)[aprox. 5 p.]. Disponible en: https://www.archivosdemedicina.com/medicina-de-familia/siacutendrome-metaboacutelico-en-adultos-revisioacuten-narrativa-de-la-literatura.pdf

  6. Khera R, Murad MH, Chandar AK. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424-34. DOI: https://doi.org/10.1001/jama.2016.7602

  7. Ashrafian H, Toma T, Rowland SP, Harling L, Tan A, Efthimiou E, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. 2015;25(7):1239-50. DOI: https://doi.org/10.1007/s11695-014-1533-2

  8. Ramírez Avilés E, Espinosa González O, Amado Galván M, Maydon H. Evolution of type 2 diabetes and carbohydrate intolerance following bariatric surgery in a Mexican mestizo population. Cir Cir. 2017;85(2):135-42. DOI: https://doi.org/10.1016/j.circir.2016.07.005

  9. Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016;39(6):902-11. DOI: https://doi.org/10.2337/dc16-0382

  10. Schauer PR, Bhatt DL, Kirwan JP. Bariatric surgery versus intensive medical therapy for diabetes 5-year outcomes. N Engl J Med. 2017 [acceso: 22/12/2020];366(17):641-51. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa1600869

  11. Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obesity Surgery. 2017; 27(2):2724-32. DOI: https://doi.org/10.1007/s11695-017-2866-4

  12. Musleh M, Carrillo K, Braghetto I. Restrictive bariatric surgery techniques: evolution and current trends. Medwave. 2012 [acceso: 29/09/2020];12(6)[aprox. 12 p]. Disponible en: http://www.mednet.cl/link.cgi/Medwave/Revisiones/RevisionClinica/5441

  13. Zubiaga L, Ruiz J, Giner L, González J, Aguilar MM, García A, et al. Valoración del riesgo cardiovascular después de gastrectomía vertical: comparativa del IMC, la adiposidad, el índice de Framingham y el índice aterogénico como marcadores del éxito de la cirugía. Nutr Hosp. 2016;33(4):832-7. Disponible en: https://dx.doi.org/10.20960/nh.377

  14. García E, Madico MC, Lozano B, Macho S, Del Barrio MJ, García A. Tubular gastroplasty with plication: a novel bariatric surgery procedure. Metas Enferm. 2014 [acceso: 12/02/2020];17(1):56-60. Disponible en: https://www.enfermeria21.com/revistas/metas/articulo/80547/gastroplastia-tubular-plicada-una-nueva-tecnica-de-cirugia-bariatrica/

  15. Pujol J, Garcia A, Casajoana A, Secanella L, Vicens A, Masdevall C. Laparoscopic gastric plication: A new surgery for the treatment of morbid obesity. Cir Esp. 2011;89(6):356-61. DOI: https://doi.org/10.1016/j.ciresp.2011.02.005

  16. Morejón-Giraldoni A. El síndrome metabólico ¿Cómo abordar el problema? Rev Finlay. 2011 [acceso: 05/01/2020];1(2):70-3. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/45

  17. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A. On behalf of International Federation for the Surgery of Obesity and Metabolic Disorders - European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO) Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery. Obes Surg. 2014;24(1):42-55. DOI: https://doi.org/10.1007/s11695-013-1079-8

  18. Lecube A, Monereo S, Rubio M, Martínez-de-Icaya P, Martí A, Salvador J. Prevention, diagnosis and treatment of obesity. Positioning SEEDO 2016. SEEDO. 2016 [acceso: 12/02/2020];1-25. Disponible en: https://www.seedo.es/images/site/ConsensoSEEDO2016.pdf

  19. American Society for Metabolic and Bariatric Surgery. Endorsed Procedures and Devices. ASMBS. 2019 [acceso: 12/02/2020]. Disponible en: https://asmbs.org/resourses/endorsed-procedures-and-devices

  20. The International Federation for the Surgery of Obesity and Metabolic Disorders. Fourth IFSO Global Registry Report 2018. IFSO. 2019 [acceso: 20/10/2019]. Disponible en: https://www.ifso.com/pdf/4th-ifso-global-registry-report-last-2018.pdf

  21. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. 2006. [acceso: 12/02/2020]. Disponible en: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf

  22. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Fortaleza. Brasil. 2013. [acceso: 12/02/2020]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-pricipios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

  23. Rosero Ortega LY, Rosero Aguirre JA, Limones Moncada MS, Soledispa Cevallos ER. Obesidad y síndrome metabólico en pediatría. RECIMUNDO. 2019 [acceso: 12/02/2020];3(4):456-78. Disponible en: https://dialnet.unirioja.es/descarga/articulo/7402146.pdf

  24. Pereira Rodríguez JE, Melo Ascanio J, Caballero Chavarro M, Rincón Gonzales G, Jaimes Martin T, Niño Serrato R. Síndrome metabólico. Apuntes de Interés. Rev Cub Cardiol Cir Cardiovasc. 2016 [acceso: 12/02/2020];22(2):108-16. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/592

  25. Castillo Hernández JL, Cuevas González MJ, Almar Galiana M, Romero Hernández EY. Síndrome metabólico, un problema de salud pública con diferentes definiciones y criterios. Rev Médica de la Universidad Veracruzana. 2017 [acceso: 12/02/2020];17(2):7-24. Disponible en: https://www.medigraphic.com/pdfs/veracruzana/muv-2017/muv172b.pdf

  26. Sacoto Encalada A, Vintimilla Molina J, Martínez Santander C, Martínez Santander D, Vintimilla Chávez C, Bustamante Espinoza K, et al. Síndrome metabólico, estado nutricional y su relación con diferentes profesiones. Rev Latinoam Hipertensión. 2019 [acceso: 12/02/2020];14(2):219-23. Disponible en: http://www.revhipertension.com/rlh_2_2019/ecuador_sindrome_metabolico_estado_nutricional.pdf

  27. Morejón Giraldoni A, Benet Rodríguez M, Martínez de la Cotera E, García Torres D, Salas Rodríguez V, Ordúñez García P. Síndrome metabólico en un área de salud de Cienfuegos. Segunda medición de CARMEN. Rev Finlay. 2011 [acceso: 12/02/2020];1(1)[aprox. 12 p.]. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/24

  28. León Quintero N, Llamas Prieto LE, Rodriguez Rodriguez G, Sánchez Rentería M, Quintero Loreto M, Hernández Vázquez M, et al. Evaluación mediante el modelo BAROS de los resultados de pacientes con 1 año postquirúrgico de Manga y Bypass Gástrico para el tratamiento de obesidad. Rev Médica. 2019 [acceso: 12/02/2020];10(2):143-9. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=85149

  29. Escalante García M, López Rosales F, Hernández Escalante VM, Martínez Díaz G, Torres Escalante JL, Castro Sansores CJ. Remisión de síndrome metabólico con cirugía bariátrica. Med Int Méx. 2018;34(5):678-82. DOI: https://doi.org/10.24245/mim.v34i5.2026

  30. Builes Gutiérrez AM, Ortiz Ramírez L, Valencia Urrea P, López Pompey N. Características clínicas, bioquímicas y complicaciones de los pacientes sometidos a la cirugía bariátrica con 18 meses de seguimiento en un hospital de alta complejidad. Iatreia. 2019;32(1):16-24. DOI: https://doi.org/10.17533/udea.iatreia.v32n1a02

  31. Sabench F, Domínguez E, Ibarzabal A. Criterio de calidad en cirugía bariátrica: revisión de conjunto y recomendaciones de la Asociación Española de Cirujanos y de la Sociedad Española de Cirugía de la Obesidad. CIR ESP. 2017;95(1):4-16. DOI: https://doi.org/10.1016/j.ciresp.2016.09.007

  32. Gálvez Valdovinos R, Marín Santillán E, Funes Rodríguez F, Mendoza Rodríguez A, Arellano G, Flores Martínez J, et al. Estudio prospectivo comparativo de bypass gástrico laparoscópico vs. gastrectomía vertical laparoscópica. Efectos sobre el síndrome metabólico. Resultados a un año. Cirujano General. 2010 [acceso: 12/02/2020];32(2):83-9. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=24856

  33. Sales C. Plicatura gástrica. Revisión de 900 casos. Una realidad en Cirugía Bariátrica. BMI-Journal. 2012 [acceso: 12/02/2020];2(3):88-92. Disponible en: https://www.bmi-journal.com/index.php/bmi/article/download/98/pdf

  34. Elffers TW, de Mutsert R, Lamb HJ, de Roos A, Willems van Dijk K, Rosendaal FR, et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS One. 2017;12(9):e0185403. DOI: https://doi.org/10.1371/journal.pone.0185403

  35. Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261(12):459-67. DOI: https://doi.org/10.1097/SLA.0000000000000863

  36. Al Khalifa K, Al Ansari A, Alsayed A, Claudio V. The impact of sleeve gastrectomy on hyperlipidemia: a systematic review. J Obes. 2013;2013(34):1-7. DOI: https://doi.org/10.1155/2013/643530

  37. Molina Ayala M, Rodríguez González A, Albarrán Sánchez A, Ferreira Hermosillo A, Ramírez Rentería C, Luque de León E, et al. Características clínicas y bioquímicas de pacientes con obesidad extrema al ingreso y un año después de someterse a cirugía bariátrica. Rev Med Inst Mex Seguro Soc. 2016;54(Suppl 2):S118-23. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2016/ims162b.pdf

  38. Corcelles R, Daigle C, Schauer P. Management of endocrine disease: Metabolic effects of bariatric surgery. Eur J Endocrinol. 2016 [acceso: 12/02/2020];174(1):19-28. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26340972

  39. Cummings D. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes. 2009;33(Supl 1):S33-40. DOI: https://doi.org/10.1038/ijo.2009.15

  40. Arterburn D, McCulloch D. Bariatric surgery for Type 2 Diabetes: Getting closer to the Long-term Goal. JAMA. 2016;315(12):1276-7. DOI: https://doi.org/10.1001/jama.2016.1884

  41. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Delegates of the 2nd diabetes surgery summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(2):861-77. DOI: https://doi.org/10.2337/dc16-0236

  42. Lemus R, Karni D, Hong D, Gmora S, Breau R, Anvari M. The impact of bariatric surgery on insulin-treated type 2 diabetes patients. Surgical Endoscopy. 2018;32(2):990-1001. DOI: https://doi.org/10.1007/s00464-017-5777-5

  43. Sapunar J, Escalona A, Araya AV, Aylwin CG, Bastías MJ, Boza C, et al. Rol de la cirugía bariátrica/metabólica en el manejo de la diabetes mellitus 2. Consenso SOCHED/SCCBM. Rev Med Chile. 2018;146(1):1175-83 DOI: http://dx.doi.org/10.4067/S0034-98872018001001175

  44. Villena López EL, Barreda Zaleta L, Sánchez Luna JP, Camacho JO. Efecto en el control glucémico y modificación del tratamiento en pacientes sometidos a cirugía bariátrica. Med Int Mex. 2018;34(3):423-34. DOI: https://doi.org/10.24245/mim.v34i3.1706

  45. Soca M. Obesidad abdominal, dislipidemia y presión arterial. Rev Finlay. 2015 [acceso: 12/02/2020];5(4)[aprox. 2 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/366

  46. Schiavon CA, Ferreira A, Santucci E, Dantas de Oliveira J. Effects of bariatric surgery in obese patients with hypertension: The GATEWAY randomized trial (gastric bypass to treat obese oatients with steady hypertension). Circulation. 2018;137(11):1132-42. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.032130

  47. Mateo Gavira I, Vílchez López FJ, Mayo Ossorio MÁ, Medina Rivero D, Sánchez Toscano E, Pacheco García JM, et al. Resultados metabólicos de la cirugía bariátrica. Impacto sobre el riesgo cardiovascular. Cir Andal. 2019 [acceso: 12/02/2020];30(4):510-4. Disponible en: https://www.asacirujanos.com/admin/upfiles/revista/2019/Cir_Andal_vol30_n4.pdf

  48. Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N. Metabolic syndrome remission after Rouxen-Y gastric bypass or sleeve gastrectomy. Diabetes Metab Syndr Obes. 2017;10(2):393-402. DOI: https://doi.org/10.2147/DMSO.S142731




2020     |     www.medigraphic.com